logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
Showing 1 - 20 of 51 Items
Showing 1 - 20 of 51 Items
Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.
  • Current Page (20)
  • CSV
  • BibTeX
  • EndNote
  • All Results (51)
  • CSV
  • BibTeX
  • EndNote
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Review

The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: A systematic review and individual-participant meta-analysis

Martinez L, Campbell JI, Linde L, Boulahbal F, Cayla JA,  et al.
2025-09-23 • American Journal of Respiratory and Critical Care Medicine
2025-09-23 • American Journal of Respiratory and Critical Care Medicine

RATIONALE

Recent empirical research suggests isoniazid may lead to a risk reduction ...

Conference Material
|
Slide Presentation
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Short Report
Journal Article
|
Research
Journal Article
|
Letter

Outcomes in Adolescents Undergoing Treatment for Drug-Resistant Tuberculosis in Mumbai

Isaakidis P, Das M, Saranchuk P
2015-07-14 • Archives of Pediatric Infectious Diseases
2015-07-14 • Archives of Pediatric Infectious Diseases
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Commentary

HIV viral load messages should go viral in India

Isaakidis P, Gupta S, Das M, Ferrer D, Nalinikanta R,  et al.
2015-09-24 • Lancet HIV
2015-09-24 • Lancet HIV
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Letter

Community based person-centered TB care by trained TB survivors under Unite to ACT project in India​ ​

Das M, Kalra A, Mohapatra S, Kumar S, Panda A,  et al.
2024-11-08 • MSF Scientific Days Asia 2024
2024-11-08 • MSF Scientific Days Asia 2024

Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India

Mongia H, Mamnoon F, Silsarma A, Mahajan R, Dalal A,  et al.
2024-04-01 • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
2024-04-01 • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

BACKGROUND 

World Health Organization suggests concurrent bedaquiline-delamanid (BDQ-DLM) as part of individualised r...

Operationalising targeted next-generation sequencing for routine diagnosis of drug-resistant TB

Iyer AS, Ndlovu Z, Sharma J, Mansoor H, Bharati M,  et al.
2023-06-21 • Public Health Action
2023-06-21 • Public Health Action
BACKGROUND
Phenotypic drug susceptibility testing (pDST) for Mycobacterium tuberculosis can take up to 8 weeks, while conventional molecular tests identify a limited set of resistanc...

Comparing Yield and Relative Costs of WHO TB Screening Algorithms in Selected Risk Groups Among People Aged 65 Years and Over in China, 2013

Zhang C, Ruan Y, Cheng J, Zhao F, Xia Y,  et al.
2017-06-08 • PLOS One
2017-06-08 • PLOS One
To calculate the yield and cost per diagnosed tuberculosis (TB) case for three World Health Organization screening algorithms and one using the Chinese National TB program (NTP) TB suspe...

Surgical interventions for pulmonary tuberculosis in Mumbai, India: Surgical outcomes and programmatic challenges India: surgical outcomes and programmatic challenges

Shirodkar S, Anande L, Dalal A, Desai C, Correa G,  et al.
2016-09-21 • Public Health Action
2016-09-21 • Public Health Action
SETTING
While surgery for pulmonary tuberculosis (PTB) is considered an important adjunct for specific cases, including drug-resistant tuberculosis, operational evidence on its feasi...

Impact of intensified case-finding strategies on childhood TB case registration in Nepal

Joshi B, Chinnakali P, Shrestha A, Das M, Kumar AMV,  et al.
2015-06-21 • Public Health Action
2015-06-21 • Public Health Action
SETTING
Seven intervention districts with intensified childhood tuberculosis (TB) case-finding strategies implemented by a non-governmental organisation and seven control districts u...

Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India

Dhakulkar S, Das M, Sutar N, Oswal V, Shah D,  et al.
2021-02-18 • PLOS One
2021-02-18 • PLOS One
BACKGROUND
Childhood and adolescent drug-resistant TB (DR-TB) is one of the neglected infectious diseases. Limited evidence exists around programmatic outcomes of children and adoles...

Treating All Multidrug-Resistant Tuberculosis Patients, Not Just Bacteriologically Confirmed Cases

Das M, Isaakidis P, Van der Bergh R, Kumar AMV, Sharath BN,  et al.
2016-06-21 • Public Health Action
2016-06-21 • Public Health Action

Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India

Laxmeshwar C, Das M, Mathur T, Israni T, Jha S,  et al.
2022-02-11 • PLOS One
2022-02-11 • PLOS One
BACKGROUND
People with drug-resistant tuberculosis (DR-TB) are known to suffer from many mental-health disorders. This study aims to describe the proportion of patients diagnosed wit...

Ocular adverse events in drug sensitive TB patients on daily fixed dose combination anti-TB drugs: A record review study from Kerala, India

Manu MS, Mehta K, Das M, Balakrishnan S, Rakesh PS,  et al.
2020-02-28 • Indian Journal of Tuberculosis
2020-02-28 • Indian Journal of Tuberculosis
BACKGROUND:Government of India's Revised National TB Control Programme (RNTCP) has begun implementing daily fixed dose combination (FDC) anti-TB treatment regimen for drug sensitive TB p...

Intensified tuberculosis case finding amongst vulnerable communities in southern India

Reddy K, Ananthakrishnan R, Jacob AG, Das M, Isaakidis P,  et al.
2015-12-21 • Public Health Action
2015-12-21 • Public Health Action
India mainly uses passive case finding to detect tuberculosis (TB) patients through the Revised National Tuberculosis Control Programme (RNTCP). An intensified case finding (ICF) interve...

Clinical utility of target-based next-generation sequencing for drug-resistant TB

Mansoor H, Hirani N, Chavan VV, Das M, Sharma J,  et al.
2023-01-01 • International Journal of Tuberculosis and Lung Disease
2023-01-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
In high TB burden countries, access to drug susceptibility testing is a major bottleneck. Targeted next-generation sequencing (tNGS) is a promising technology for rapid re...

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India

Das M, Andries A, Deshpande A, Mansoor H, Saranchuk P,  et al.
2014-07-30 • Global Health Action
2014-07-30 • Global Health Action
There are limited data on the failure of second-line antiretroviral therapy (ART) and the use of third-line ART in people living with HIV in resource-limited settings. Since 2011, the Mé...

Infection control in households of drug-resistant tuberculosis patients co-infected with HIV in Mumbai, India

Albuquerque T, Isaakidis P, Das M, Saranchuk P, Andries A,  et al.
2014-03-21 • Public Health Action
2014-03-21 • Public Health Action
Background: Mumbai has a population of 21 million, and an increasingly recognised epidemic of drug-resistant tuberculosis (DR-TB). Objective: To describe TB infection control (IC) measur...

Self-Administered Tuberculosis Treatment Outcomes in a Tribal Population on the Indo-Myanmar Border, Nagaland, India

Das M, Isaakidis P, Shenoy R, Anicete R, Sharma H,  et al.
2014-09-26 • PLOS One
2014-09-26 • PLOS One
Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage of tuberculosis treatment. However, populations living in 'hard-to-reach' are...

Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges

Chavan VV, Dalal A, Nagaraja SB, Thekkur P, Mansoor H,  et al.
2020-06-16 • PLOS One
2020-06-16 • PLOS One
Background
Imipenem, an intravenous antibiotic is recommended for use in drug resistant tuberculosis (DR-TB) when an effective regimen with combination of other second line drugs is...

Viral load for HIV treatment failure management: a report of eight drug-resistant tuberculosis cases co-infected with HIV requiring second-line antiretroviral treatment in Mumbai, India

Andries A, Das M, Isaakidis P, Saranchuk P
2013-12-01 • American Journal of Tropical Medicine and Hygiene
2013-12-01 • American Journal of Tropical Medicine and Hygiene